from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1201c/dapD

LFCtreatmentdescriptionclass of inhibitor

-0.539

Amikacinug/mL Amikacintranslation

-0.589

Cap5-10ug/mL Capreomycintranslation

-1.613

Rox10-50 ug/mL Roxithromycintranslation

-0.002

SM2-5 ug/mL Streptomycintranslation

-2.954

Tet5-10 ug/mL Tetracyclinetranslation

0.465

Rif0.2-5ug/mL Rifampicintranscription

-0.182

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.549

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.534

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.826

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.886

Clofazimine10-13 ug/mL Clofaziminerespiration

0.385

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.033

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.575

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.002

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.423

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.592

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.957

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.427

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.049

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.221

KCN5-20 ug/mL Potassium cyaniderespiration

0.143

NaN30.2-2 mM Sodium aziderespiration

0.382

Nigericin50 uM Nigericinrespiration

-1.516

TRC10-150 ug/mL Triclosanrespiration

-1.256

TRZ10-25 ug/mL Thioridazinerespiration

-1.145

Valinomycin0.5-10 uM Valinomycinrespiration

0.172

ZnSO42 mM ZnSO4respiration

0.012

menadione6-10 ug/mL Menadionerespiration

-0.640

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.639

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.195

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.174

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.919

NRP_1Non-replicating persistence stage 1dosRassociated

0.144

Amp0.2mg/mL AmpicillincellWall

0.141

Cephalexin20-100 ug/mL CephalexincellWall

-0.021

Cerulenin0.32-5 ug/mL CerulenincellWall

1.733

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.548

EMB10-20 ug/mL EthambutolcellWall

0.803

Eta12-40 ug/mL EthionamidecellWall

0.918

INH0.2-0.4 ug/mL IsoniazidcellWall

0.594

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.095

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.182

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.499

BZA0.12 mg/mL BenzamidearomaticAmides

0.417

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.051

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.440

H2O24 mM hydrogen peroxideDNAdamaging

0.558

Levo10 ug/mL LevofloxacinDNAdamaging

0.849

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.136

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.227

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.286

UVUV-irradiationDNAdamaging

-0.897

ARP41-4 ug/mL Antitubercular compound ARP4?

0.396

Antimycin12.5-50 ug/mL Antimycin A?

0.208

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.094

PA_110-50 ug/mL Antitubercular compound PA-1?

0.011

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.871

PA8240.2-2 ug/mL PA-824?

-0.427

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.429

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.091

Verapamil50 uM Verapamil?

0.239

mercaptoethanol2 mM 2-Mercaptoethanol?

0.162

methoxatin10-20 ug/mL Methoxatin?